COMPANY OVERVIEW

Enzyvant is a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases

---

LOCATION

Cambridge, MA, USA

Basel, , Switzerland

---

THERAPEUTIC AREAS

Rare Diseases

---

WEBSITE

https://www.enzyvant.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Dec 6, 2022

Enzyvant Announces Merger with Altavant

Jun 27, 2022

Enzyvant Receives 2022 Rare Impact Industry Innovation Award from the National Organization for Rare Disorders (NORD) for Novel, Tissue-Based Therapy to Treat Ultra-Rare, Life-Threatening Pediatric Condition

Apr 21, 2022

Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing Capabilities

Apr 21, 2022

Jan 26, 2022

Enzyvant Appoints Johanna Rossell as Chief Commercial Officer

For More Press Releases

---